Clinical trial
Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients…
NCT00186979 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186979 |
|---|---|
| Title | Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors |
| Official title | A Phase I Study of ZD1839 (Iressa) in Combination With Irinotecan (Camptosar or CPT-11) and Vincristine in Pediatric Patients With Refractory Solid Tumors |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | AstraZeneca Industry National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumors |
| Intervention type | Drug |
| Interventions | Irinotecan, ZD1839, Vincristine, Cefixime, Cefpodoxime. |
| Enrollment | 34 |
| Start date | May 1, 2003 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: